Skip to main content Accessibility help

Disorders of the upper gastrointestinal tract

  • AF Safe (a1)


  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.


Corresponding author

AF Safe, Barnsley District General Hospital, Gawber Road, Barnsley, South Yorkshire S75 2EP, UK.


Hide All
1Palemans, W, Vantrappen, G. Oesophageal disease in the elderly. Clin Gastroenterol 1985; 14: 635–56.
2Andrews, GR, Haneman, B, Arnold, BJ, Booth, JC, Taylor, K. Atrophic gastritis in the aged. Aust Ann Med 1967; 61: 230–35.
3Holt, PR, Rosenberg, IH, Russell, RM. Causes and consequences of hypochlorhydria in the elderly. Dig Dis Sci 1989; 34: 933–37.
4Strickland, RG, Bhathal, PS, Korman, MG, Hansky, J. Serum gastrin and antal mucosa in atrophic gastritis. BMJ 1971; 4: 451–53.
5Dooley, CP, Cohen, H, Fitzgibbons, PL et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–66.
6Sobala, GM, King, RF, Axon, AT, Dixon, MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43: 303306.
7Holt, PR. The small intestine. Clin Gastroenterol 1985; 14: 689723.
8Dent, J. Recent reviews on the pathogenesis of gastro-oesophageal reflux disease. Baillières Clin Gastroenterol 1987; 1: 727–46.
9Moran, BJ, Taylor, MB, Johnson, CD. Percutaneous endoscopic gastrostomy. Br J Surg 1990; 77: 858–62.
10Worman, LW. Pharyngeo-oesophageal diverticulum –excision or incision. Surgery 1980; 87: 236–37.
11Weinbeck, M, Berges, W, Freiling, T. Therapeutic advances in oesophageal motility disorders. Baillières Clin Gastroenterol 1987; 1: 857–67.
12Blackwell, JN, Castell, DO. Oesophageal motility: recent advances and implications. Clin Sci 1984; 104: 477–83.
13Clouse, RE, Staiano, A. Contraction abnormalities of the oesophageal body in patients referred for manometry: a new approach to manometric classification. Dig Dis Sci 1983; 28: 784–91.
14Dimarino, AJ, Cohen, S. Characteristics of lower oesophageal sphincter function in symptomatic diffuse oesophageal spasm. Gastroenterology 1974; 66: 16.
15Csendes, A, Braghetto, I, Henriquez, A, Cortes, A. Late results of a prospective randomised study comparing forceful dilatation and oesophogomyotomy in patients with achalasia. Gut 1989; 30: 299304.
16Spechler, SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 (suppl 1): 2429.
17Dent, J, Holloway, RH, Toouli, J, Dodds, WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988; 29: 1020–28.
18Ott, DJ, Gelfand, DW, Wu, WC. Sensitivity of single-contrast radiology in oesophageal disease: a study of 240 patients with endoscopically verified abnormality. Gastrointest Radiol 1983; 8: 105–10.
19Ott, DJ, Dodds, WJ, Wu, WC et al. Current status of radiology in evaluating for gastrooesophgeal disease. J Clin Gastroenterol 1982; 4: 365–75.
20De Caestecker, JS, Heading, RC. Oesophageal pH monitoring. Gastroenterol Clin North Am 1990; 19: 645–69.
21Stanciu, C, Hoare, RC, Bennet, JR. Correlation between manometric and pH tests for gastro-oesophageal reflux. Gut 1977; 18: 536–40.
22Hetzel, DJ. Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion 1992; 51 (suppl 1): 3542.
23Solcia, E, Fiocca, R, Havu, N, Dalvag, A, Carlsson, R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion 1992; 51 (suppl 1): 8292.
24Rosetti, M, Hell, K. Fundoplication for treatment of gastro-oesophageal reflux in hiatal hernia. World J Surg 1977; 1: 439–44.
25Dupin, B, Meric, B, Dumon, BF. Techniques, results and complications of oesophageal dilatation. Baillières Clin Gastroenterol 1987; 1: 809–20.
26Atkinson, M. Barrett's oesophagus – to screen or not to screen? Gut 1989; 30: 25.
27Hameerteman, W, Houthoff, HJ, Tytgat, GNJ. Early diagnosis of Barrett's carcinoma. Scand J Gastroenterol 1988; 23: 611.
28Quint, LE, Glazer, GM, Orringer, MB. Oesophageal imaging by MRI and CT: study of normal anatomy and neoplasm. Radiology 1985; 156: 727–31.
29Louizou, LA, Grigg, D, Atkinson, M et al. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology 1991; 100: 1303–10.
30McCaughan, JS, Nims, TA, Guys, JT et al. Photodynamic therapy for oesophageal tumours. Arch Surg 1989; 124: 7480.
31Hagenmuller, F, Sander, C, Sander, R, Ries, G, Classen, M. Palliation of obstructive oesophageal and cardial carcinomas with laser and endoluminal iridium radiation. Baillières Clin Gastroenterol 1987; 1: 917–22.
32Wolfe, WG, Burton, GV, Seillger, HF et al. Early results with combined modality therapy for carcinoma of the oesophagus. Ann Surg 1987; 205: 563–71.
33Diehl, JT, Hermann, RE, Cooperman, AM, Hoerr, SO. Gastric carcinoma: a ten-year review. Ann Surg 1983; 198: 912.
34Steinheber, FU. Ageing and the stomach. Clin Gastroenterol 1985; 14: 657–88.
35Kurata, JH, Corboy, ED. Current peptic ulcer time trends. An epidemiological profile. J Clin Gastroenterol 1988; 10: 259–68.
36Tasman-Jones, C. Pathogenesis of peptic ulcer disease and gastritis: importance of aggressive and cytoprotective factors. Scand J Gastroenterol 1986; 21 (suppl 122): 15.
37Tasman-Jones, C, Maher, C, Thomsen, L, Lee, SP, Vanderwee, M. Mucosal defences and gastroduodenal disease. Digestion 1987; 37: 17.
38Corfield, A, Wagner, SA, Safe, AF, Mountford, RA, Clamp, JR. Sialic acid in human gastric aspiration. Clin Sci 1993; 84: 573–79.
39Marshall, BJ, Warren, RJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311–15.
40O'Connor, HJ, Dixon, MF, Wyatt, JI et al. Campylobacter pylori and peptic ulcer disease. Lancet 1987; ii: 633–34.
41Rokkas, T, Pursey, C, Uzoechina, E et al. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987; 82: 1149–52.
42Forman, D, Newell, DG, Fullerton, F et al. Association between infection with Helicobacter pylori infection and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302–305.
43Veenendaal, RA, Pena, AS, Maijer, JL et al. Long-term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291–94.
44Sobala, GM, Crabtree, JE, Pentith, JA et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 9496.
45Duggan, JM, Dobson, AJ, Johnson, H, Fahey, P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986; 27: 929–33.
46Jolobe, OM, Montgomery, RD. Changing clinical pattern of gastric ulcer: are anti-inflammatory drugs involved? Digestion 1984; 29: 164–70.
47Armstrong, CP, Blower, AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28: 527–32.
48 Collier DSI, Pain, JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63.
49Jones, ST, Clague, RB, Eldridge, J, Jones, DM. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991; 30: 1620.
50Graham, DY, Lew, GM, Evans, DG et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266–69.
51Goodwin, CS, McNulty, CAM. Bacteriological and pharmacological basis for the treatment of Helicobacter pylori infection. In: Rathbone, BJ, Heatley, RV eds. Helicobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific Publications, 1992: 224–31.
52Suerbaun, S, Leying, H, Klemm, K, Opferkuch, W. Antibacterial activity of pantonazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 9293.
53Labenz, J, Gyenes, E, Ruhl, GH, Borsch, G. Omeprazole plus amoxycillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491–95.
54Morgan, AG, Clamp, SE. OMGE international gastrointestinal bleeding survey, 1978–1986. Scand J Gastroenterol Suppl 1988; 144: 5158.
55Wara, P, Berg, V, Amdrup, E. Factors influencing mortality in patients with bleeding peptic ulcer. Acta Clin Scand 1983; 149: 775–85.
56Holman, RAE, Davis, M, Gough, KR, Cartell, P, Britton, DC, Smith, RB. Value of centralised approach in management of haematemesis and melaena: experience in a district general hospital. Gut 1990; 31: 504508.
57Llwellyn, JG, Pritchard, MH. Influence of age and disease state in nonsteroidal anti-inflammatory drug-associated gastric bleeding. J Rheumatol 1988; 15: 691–94.
58Allan, R, Dykes, PW. A study of factors influencing mortality rates from gastrointestinal haemorrhage. Q J Med 1976; 45: 533–50.
59Clason, AE, Macleod, DAD, Elton, RA. Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal haemorrhage. Br J Surg 1986; 73: 985–87.
60Swaine, CP, Story, DW, Brown, SG et al. Nature of the bleeding vessel in recurrently bleeding gastric ulcers. Gastroenterology 1986; 90: 595608.
61Collins, R, Langman, MJS. Treatment with histamine H2 antagonists in acute upper gastrointestinal haemorrhage: implications of randomised trials. N Eng J Med 1985; 313: 660–66.
62Haglund, U. Role of histamine H2receptor antagonists in non-operative management of gastroduodenal ulcer haemorrhage. Scand J Gastroenterol Suppl 1987; 137: 3942.
63Daneshmed, TK, Hawkey, CJ. Langman, MJS et al. Omeprazole v. placebo for acute upper gastrointestinal bleeding: a randomised double-blind controlled trial in 1154 patients. Gut 1990; 31: 1206 (Abstract).
64Barer, D, Ogilvie, AL, Henry, DA et al. Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal bleeding. N Eng J Med 1983; 308: 1571–75.
65Henry, DA, O'Connel, D. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ 1989; 289: 1142–46.
66Sacks, HS, Chalmers, TC, Blum, AL et al. Endoscopic haemostasis. An effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494–99.
67Steele, RJC. Endoscopic haemostasis for non-variceal upper gastrointestinal haemorrhage. Br J Surg 1989; 76: 219–25.
68Teenan, RP, Murray, WR. Late outcome of undersewing alone for gastric ulcer haemorrhage. Br J Surg 1990; 77: 811–12.
69Falk, GL, Hollinstead, JW, Gillett, DJ. Highly selective vagotomy in the treatment of complicated duodenal ulcer. Med J Aust 1990; 152: 574–76.
70Pinto-Correia, J, Martins, Alves M, Alexandrino, P, Silveira, J. Controlled trial of vasopressin and balloon tamponade in bleeding oesophageal varices. Hepatology 1984; 4: 885–88.
71Khan, D, Bornman, JC, Terblanche, J. A 10-year prospective evaluation of balloon tamponade and emergency injection sclerotherapy for actively bleeding oesophageal varices. Hepatopancreatobil Surg 1989; I: 207–11.
72Larson, AW, Cohen, H, Zweiban, B et al. Acute oesophageal varices sclerotherapy. Results of a prospective randomised controlled trial. JAMA 1986; 255: 497500.
73Jensen, LS, Kararup, N. Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 1989; 24: 339–45.
74Bullinore, DW, Miloszewski, KJA, Losowsky, MS. The prognosis of elderly subjects with oesophageal varices. Age Ageing 1989; 18: 3538.
75Mc Evoy, A, Dutton, J, James, OFW. Bacterial contamination of small intestine is an important cause of occult malabsorption in the elderly. BMJ 1983; 287: 789–93.
76Montgomery, RD, Haboubi, NY, Mike, NH, Chesner, IM, Asquith, P. Causes of malabsorption in the elderly. Age Ageing 1986; 15: 235–40.
77Corazza, GR, Menozzi, MG, Strocchi, A et al. The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990; 98: 302307.

Related content

Powered by UNSILO

Disorders of the upper gastrointestinal tract

  • AF Safe (a1)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.